ES2057749T3 - Medicamento simulado parecido a una capsula con doble recubrimiento interno. - Google Patents

Medicamento simulado parecido a una capsula con doble recubrimiento interno.

Info

Publication number
ES2057749T3
ES2057749T3 ES91300453T ES91300453T ES2057749T3 ES 2057749 T3 ES2057749 T3 ES 2057749T3 ES 91300453 T ES91300453 T ES 91300453T ES 91300453 T ES91300453 T ES 91300453T ES 2057749 T3 ES2057749 T3 ES 2057749T3
Authority
ES
Spain
Prior art keywords
capsule
internal coating
double internal
simulated
medicine similar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91300453T
Other languages
English (en)
Inventor
Marli F Batista
Thomas J Markley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kenvue Brands LLC
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Application granted granted Critical
Publication of ES2057749T3 publication Critical patent/ES2057749T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

EL MEDICAMENTO DE UNA CAPSULA SIMULADA COMPRENDE UN DOBLE REVESTIMIENTO, COMPUESTO POR UN REVESTIMIENTO INICIAL DE UN POLIMERO SOLUBLE EN AGUA, EJ: POVIDONA Y OTRO REVESTIMIENTO DE UNA MEZCLA DE DOS PELICULAS FORMADAS DE POLIMEROS, EJ: POVIDONA Y METILCELULOSA HIDROXYPROPILICA Y UN PLASTICO HIDROFOBICO, EJ: ACEITE RICINO, EL CUAL FACILITA UNA UNIFORMIDAD SUAVE Y SUSTANCIALMENTE LIBRE DE BURBUJAS, PARA LOS REVESTIMIENTOS DE CAPSULAS; Y EL PROCESO PARA FABRICAR DICHOS MEDICAMENTOS.
ES91300453T 1990-01-22 1991-01-21 Medicamento simulado parecido a una capsula con doble recubrimiento interno. Expired - Lifetime ES2057749T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/468,434 US5198227A (en) 1990-01-22 1990-01-22 Dual subcoated simulated capsule medicament

Publications (1)

Publication Number Publication Date
ES2057749T3 true ES2057749T3 (es) 1994-10-16

Family

ID=23859800

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91300453T Expired - Lifetime ES2057749T3 (es) 1990-01-22 1991-01-21 Medicamento simulado parecido a una capsula con doble recubrimiento interno.

Country Status (15)

Country Link
US (2) US5198227A (es)
EP (1) EP0439315B1 (es)
JP (1) JP3091770B2 (es)
KR (1) KR100195570B1 (es)
AT (1) ATE110263T1 (es)
AU (1) AU633394B2 (es)
CA (1) CA2032592C (es)
DE (1) DE69103538T2 (es)
ES (1) ES2057749T3 (es)
GR (1) GR1002293B (es)
IE (1) IE64295B1 (es)
IN (1) IN171949B (es)
NZ (1) NZ236798A (es)
PT (1) PT96533B (es)
ZA (1) ZA91426B (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015332A1 (en) * 1991-03-04 1992-09-17 Warner-Lambert Company Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
ES2150017T3 (es) * 1994-12-16 2000-11-16 Warner Lambert Co Proceso de encapsulacion de comprimidos en una capsula y formas de dosificacion solidas obtenidas por este proceso.
US6245350B1 (en) 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
US5776490A (en) * 1996-01-26 1998-07-07 The Center For Innovative Technology Complex protein-walled microcapsules containing lipid-walled microcapsules and method for producing same
JP3001440B2 (ja) * 1996-11-25 2000-01-24 日本電気通信システム株式会社 仮想ｌａｎ方式
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
IN186245B (es) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US20050079214A1 (en) * 1999-09-01 2005-04-14 John Cooker Oral delivery system and method for making same
US6656501B1 (en) 1999-09-01 2003-12-02 John T. Cooker Oral delivery system and method for making same
US6254888B1 (en) * 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
US20070059367A1 (en) * 2000-06-06 2007-03-15 Cherukuri S R Drug Delivery System and Associated Methods
US7678387B2 (en) * 2000-06-06 2010-03-16 Capricorn Pharma, Inc. Drug delivery systems
US20100196466A1 (en) * 2000-06-06 2010-08-05 Capricorn Pharma Inc. Drug delivery system
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
WO2002072033A2 (en) * 2001-03-13 2002-09-19 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms containing glucocorticosteroid
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20030072729A1 (en) * 2001-05-15 2003-04-17 Christopher Szymczak Simethicone as weight gain enhancer
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7169450B2 (en) * 2002-05-15 2007-01-30 Mcneil-Ppc, Inc. Enrobed core
US6946156B2 (en) * 2002-05-15 2005-09-20 Mcneil-Ppc, Inc. Process for enrobing a core
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
AP2006003585A0 (en) * 2003-09-19 2006-04-30 Penwest Pharmaceuticals Co Delayed release dosage forms.
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
ES2607988T3 (es) 2005-05-31 2017-04-05 Iams Europe B.V. Bifidobacterias probióticas felinas
ATE512211T1 (de) 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
ES2551719T3 (es) 2007-02-01 2015-11-23 Iams Europe B.V. Procedimiento para disminuir la inflamación y el estrés en un mamífero usando antimetabolitos de glucosa, aguacate o extractos de aguacate
DE102007026037A1 (de) 2007-06-04 2008-12-11 Lts Lohmann Therapie-Systeme Ag Gastroretentives System mit Alginat-Körper
US20090074866A1 (en) * 2007-09-17 2009-03-19 Jen-Chi Chen Dip coated compositions containing copolymer of polyvinyl alcohol and polyethylene glycol and a gum
ES2384305T3 (es) * 2008-02-19 2012-07-03 Mcneil-Ppc, Inc. Composiciones de revestimiento por inmersión que contienen un almidón con elevado contenido de amilosa
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CA2746709A1 (en) * 2008-12-23 2010-07-01 Harmonium International Inc. Turbine coating apparatus and spray gun assembly therefor
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
JP6086857B2 (ja) * 2013-11-15 2017-03-01 ティーエスフーズ株式会社 冷凍餃子及び冷凍餃子の製造方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US599865A (en) * 1898-03-01 Emanuel l
US3185626A (en) * 1963-03-06 1965-05-25 Sterling Drug Inc Tablet coating method
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
CA1223209A (en) * 1983-04-07 1987-06-23 Thomas M. Tencza Capsule shaped tablets
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
CA1217140A (en) * 1983-06-22 1987-01-27 Thomas M. Tencza Thin film coated tablets
DE3678643D1 (de) * 1985-08-16 1991-05-16 Procter & Gamble Partikel mit konstanter wirkstofffreisetzung.
US4928840A (en) * 1986-02-25 1990-05-29 American Home Products Corporation Tamper proof encapsulated medicaments
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
US4966771A (en) * 1987-02-20 1990-10-30 Mcneilab, Inc. Gelatin coated caplets and process for making same
US4820524A (en) * 1987-02-20 1989-04-11 Mcneilab, Inc. Gelatin coated caplets and process for making same
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
US4951230A (en) * 1987-10-26 1990-08-21 Tektronix, Inc. Method and apparatus for tiling an image
US4857337A (en) * 1988-05-24 1989-08-15 American Home Products Corp. (Del) Enteric coated aspirin tablets
DE69014092T2 (de) * 1989-12-29 1995-06-01 Bristol Myers Squibb Co Kombination einer Kapsel und Kaplet.
US5089270A (en) * 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5188688A (en) * 1990-07-20 1993-02-23 Minnesota Mining And Manufacturing Company Method of sealing a gelatin capsule
US5114720A (en) * 1990-12-27 1992-05-19 American Cyanamid Company Gelatin coated tablets and method for producing same

Also Published As

Publication number Publication date
JPH04210913A (ja) 1992-08-03
US5198227A (en) 1993-03-30
GR910100028A (el) 1992-06-25
KR100195570B1 (ko) 1999-06-15
DE69103538D1 (de) 1994-09-29
AU633394B2 (en) 1993-01-28
IE64295B1 (en) 1995-07-26
CA2032592C (en) 1996-02-13
CA2032592A1 (en) 1991-07-23
EP0439315A1 (en) 1991-07-31
IN171949B (es) 1993-02-13
ATE110263T1 (de) 1994-09-15
PT96533B (pt) 1998-07-31
JP3091770B2 (ja) 2000-09-25
US5296233A (en) 1994-03-22
ZA91426B (en) 1992-09-30
DE69103538T2 (de) 1994-12-22
PT96533A (pt) 1991-10-15
NZ236798A (en) 1993-03-26
GR1002293B (el) 1996-05-03
IE910190A1 (en) 1991-07-31
EP0439315B1 (en) 1994-08-24
KR910014110A (ko) 1991-08-31
AU6989291A (en) 1991-07-25

Similar Documents

Publication Publication Date Title
ES2057749T3 (es) Medicamento simulado parecido a una capsula con doble recubrimiento interno.
ES2062355T3 (es) Composicion farmaceutica que comprende loratadina, ibuprofeno y pseudoefedrina.
ES2008580A6 (es) Forma de dosificacion para la liberacion rapida y lenta de agente beneficioso.
CO4770978A1 (es) Empleo de epinastina para el tratamiento de dolores
DE69805001D1 (de) Osmotische darreichungsform mit zwei mantelschichten
ES2031238T3 (es) Aparato distribuidor con matriz movil que incluye una pluralidad de pildoras de tamano reducido.
ES2031597T3 (es) Aparato distribuidor con un miembro dispensador para entregar un agente beneficioso.
ES2056660T3 (es) Forma de dosificacion para pautas de suministro de farmacos variables con el tiempo.
ES2107235T3 (es) Tableta de liberacion prolongada, revestida con pelicula, de astemizol y pseudoefedrina.
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
ES2150663T3 (es) Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina.
MX9701342A (es) Formulacion cosolvente de tirilazad para administracion parenteral.
AR002275A1 (es) Forma de dosificacion farmaceutica oral, procedimiento para la manufactura de una forma de dosificacion fija, y uso de dicha forma de dosificacionfarmaceutica oral.
ES2041988T3 (es) Dispositivo que comprende medios para proteger y suministrar medicamento sensible y fluido.
ES2114562T3 (es) Forma de dosificacion para distribucion retardada de farmacos.
ES2032016T3 (es) Un procedimiento para la produccion de las 13, 14-ceto-pgfs.
CY1112361T1 (el) Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743
PE20000512A1 (es) Capsula doble para la administracion de principios activos en terapias multiples
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
ES2005914A6 (es) Metodo para determinar la fiabilidad de los preservativos masculinos.
FR2735369B1 (fr) Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
ES2097887T3 (es) Polimero de carboxivinilo con viscosidad newtoniana.
ES2196167T3 (es) Composicion farmaceutica que contiene propionato de 3-(2,2,2-trimetilhidrazinio) y gamma-butirobetaina para el tratamiento de enfermedades cardiovasculares.
ES2180729T3 (es) Tratamiento terapeutico combinado de las patologias hiperproliferantes.
ES2094834T3 (es) Dispositivo para el lavado, para finalidades terapeuticas o de higiene, de conductos internos humanos o animales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 439315

Country of ref document: ES